oncurious.com

Home Oncurious

Skip to main content. Is an oncology company focused on the development of innovative medicines for the treatment of pediatric brain tumors. Oncurious will initiate a Phase IIIa clinical program with TB-403 for the treatment of medulloblastoma, a rare, life-threatening brain tumor that mainly affects children. Enrollment of the first patient is expected for the end of 2015. BioInvent International will act as a co-development partner. For more information contact infooncurious.com.
history traffic contact

OVERVIEW

The domain oncurious.com currently has a traffic classification of zero (the smaller the higher page views). We have crawled zero pages within the domain oncurious.com and found three websites interfacing with oncurious.com. We were able to precure one contacts and directions for oncurious.com to help you connect with them. The domain oncurious.com has been on the internet for five hundred and eighty-eight weeks, nine days, seven hours, and forty minutes.
Links to this site
3
Contacts
1
Addresses
1
Online Since
Jun 2013

ONCURIOUS.COM TRAFFIC

The domain oncurious.com has seen fluctuating amounts of traffic throughout the the year.
Traffic for oncurious.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for oncurious.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for oncurious.com

Date Range

All time
This Year
Last Year
Last Month

ONCURIOUS.COM HISTORY

The domain oncurious.com was started on on June 12, 2013. This website was changed on May 31, 2014. It will go back on the market on the date of June 11, 2015. As of today, it is five hundred and eighty-eight weeks, nine days, seven hours, and forty minutes old.
REGISTERED
June
2013
UPDATED
May
2014
EXPIRED
June
2015

SITE SPAN

11
YEARS
3
MONTHS
8
DAYS

LINKS TO ONCURIOUS.COM

ThromboGenics Advancing Science. Enhancing Vision

The following webpage and information therein is intended for viewing by investment audiences only. Do you accept and agree to be bound by the above conditions? Are you a US Health Care Professional? ThromboGenics Advancing Science. Vitreomacular Adhesion and Retinal Disorders. ThromboGenics is an integrated biopharmace.

Upcoming events VIB Conference series

Metabolism in Cancer and Stromal Cells. 8-10 SEPTEMBER 2015, Leuven, Belgium. 28-29 JANUARY 2016, GENT, BELGIUM. Applied Bioinformatics in Life Sciences. 17-18 MARCH 2016, LEUVEN, BELGIUM.

WHAT DOES ONCURIOUS.COM LOOK LIKE?

Desktop Screenshot of oncurious.com Mobile Screenshot of oncurious.com Tablet Screenshot of oncurious.com

CONTACTS

ThromboGenics NV

Van Horenbeek Madi

Gaston Geenslaan 1

LEUVEN, B-3001

BE

3216751386
madi.vanhorenbeek@thrombogenics.com

ONCURIOUS.COM SERVER

We observed that a lone root page on oncurious.com took zero milliseconds to download. We could not find a SSL certificate, so our parsers consider this site not secure.
Load time
0 sec
SSL
NOT SECURE
IP
46.137.165.193

NAME SERVERS

ns1.eurodns.com
ns2.eurodns.com
ns3.eurodns.com
ns4.eurodns.com

SITE TITLE

Home Oncurious

DESCRIPTION

Skip to main content. Is an oncology company focused on the development of innovative medicines for the treatment of pediatric brain tumors. Oncurious will initiate a Phase IIIa clinical program with TB-403 for the treatment of medulloblastoma, a rare, life-threatening brain tumor that mainly affects children. Enrollment of the first patient is expected for the end of 2015. BioInvent International will act as a co-development partner. For more information contact infooncurious.com.

PARSED CONTENT

The domain oncurious.com states the following, "Is an oncology company focused on the development of innovative medicines for the treatment of pediatric brain tumors." I observed that the webpage stated " Oncurious will initiate a Phase IIIa clinical program with TB-403 for the treatment of medulloblastoma, a rare, life-threatening brain tumor that mainly affects children." They also stated " Enrollment of the first patient is expected for the end of 2015. BioInvent International will act as a co-development partner. For more information contact infooncurious."

SEE OTHER DOMAINS

Düzce Öncü Haber, Öncü TV, Öncü FM

TEKME TOKATLI YOL VERME KAVGASI. BİSİKLETİ İLE YAN YOLDAN ÇIKTI. 20 OKULDA 2 BİN ÖĞRENCİYE ULAŞILDI. TEKME TOKATLI YOL VERME KAVGASI. BİSİKLETİ İLE YAN YOLDAN ÇIKTI. PROJE İMAM HATİP LİSESİ AÇILIYOR.

Öncü Salça Öncü Salça

Baba pazarda salça sattı 5 kardeş 3 fabrikayla 55 milyon liraya çıktı. Likopen ve faydaları nelerdir? Likopen sebze ve meyvelerde doğal alarak bulunan karoten familyasına ait bir pigmenttir.

oncusanat DeviantArt

Firstart , Innovation and creativity can occur at any time in the field of artistic movement that brings together artists from the beginning. Firstart , Innovation and creativity can occur at any time in the field of artistic movement that brings together artists from the beginning.

Öncü Şehir Gazetesi

100 MİLYON VE TOPLUM! NEŞET ERTAŞ HEYKELİ NİHAYET TEMİZLENDİ. Benim için yine zor olmayan bir seçim olacak.